发明名称 Pyrimidine derivatives as FAK inhibitors
摘要 Compounds of the formula (I), in which R1, R2 and R3 have the meanings indicated in Claim 1, are kinase inhibitors and can be employed, inter alia, for the treatment of tumors.
申请公布号 US8906916(B2) 申请公布日期 2014.12.09
申请号 US201113817251 申请日期 2011.07.19
申请人 Merck Patent GmbH 发明人 Heinrich Timo;Esdar Christina;Greiner Hartmut
分类号 C07D233/88;A61K31/505;C07D401/14;C07D417/12;C07D401/12;C07D405/04;C07D413/14;C07D413/12;C07D239/42;C07D403/12;C07D401/06;C07D403/04;C07D403/14;C07D401/04;C07D417/04 主分类号 C07D233/88
代理机构 Millen, White, Zelano & Branigan, P.C. 代理人 Millen, White, Zelano & Branigan, P.C.
主权项 1. A compound selected from the the following compounds:No.Name and/or structure“A1”N-(2-{2-[2-(4-Methanesulfonylphenylamino)pyrimidin-4-yl]-ethyl}phenyl)-N-methylmethanesulfonamide“A2”N-Methyl-N-(2-{2-[2-(2-oxo-1,2,3,4-tetrahydroquinolin-6-ylamino)pyrimidin-4-yl]ethyl}phenyl)methanesulfonamide“A3”6-{4-[2-(3-Methanesulfonylphenyl)ethyl]pyrimidin-2-ylamino}-3,4-dihydro-1H-quinolin-2-one“A4”(4-Methanesulfonylphenyl)-{4-[2-(3-methanesulfonylphenyl)-ethyl]pyrimidin-2-yl}amine“A5”N-Methyl-N-(2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)methanesulfonamide“A6”N-Methyl-N-(3-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}pyridin-2-yl)methanesulfonamide“A7”N-Methyl-N-(3-{2-[2-(2-oxo-1,2,3,4-tetrahydroquinolin-6-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)methanesulfonamide“A8”N-(3-{2-[2-(4-Methanesulfonylphenylamino)pyrimidin-4-yl]-ethyl}pyridin-2-yl)-N-methylmethanesulfonamide“A9”(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}phenyl)acetonitrile“A10”N-Methyl-N-(3-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}pyridin-2-yl)acetamide“A11”(4-Fluoro-2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)acetonitrile“A12”N-Methyl-N-(3-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}pyridin-2-yl)formamide“A13”1-(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}phenyl)cyclobutanecarbonitrile“A14”N-[2-(3-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}pyridin-2-ylamino)ethyl]formamide“A15”(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}-5-trifluoromethylphenyl)acetonitrile“A16”3-(3-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)azetidine-3-carbonitrile“A17”(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}-4-trifluoromethylphenyl)acetonitrile“A18”(5-Fluoro-2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)acetonitrile“A19”1-(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}-4-trifluoromethylphenyl)cyclobutanecarbonitrile“A20”N-Methyl-N-(3-{2-[2-(2-oxo-2,3-dihydrobenzoxazol-6-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)methanesulfonamide“A21”N-Methyl-N-(3-{2-[2-(1-methyl-2-oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)methanesulfonamide“A22”N-(3-{2-[2-(3-Cyanophenylamino)pyrimidin-4-yl]ethyl}-pyridin-2-yl)-N-methylmethanesulfonamide“A23”N-(3-{2-[2-(3-Cyano-4-fluorophenylamino)pyrimidin-4-yl]-ethyl}pyridin-2-yl)-N-methylmethanesulfonamide“A24”N-Methyl-N-[3-(2-{2-[(6-oxo-1,6-dihydropyridazin-3-ylmethyl)amino]pyrimidin-4-yl}ethyl)pyridin-2-yl]-methanesulfonamide“A25”N-(3-{2-[2-(1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)-N-methylmethanesulfonamide“A26”N-(3-{[5-Cyano-2-(2-oxo-2,3-dihydrobenzoxazol-6-ylamino)-pyrimidin-4-ylamino]methyl}pyridin-2-yl)-N-methylmethanesulfonamide“A27”N-Methyl-N-(2-{2-[2-(2-oxo-2,3-dihydrobenzoxazol-6-ylamino)pyrimidin-4-yl]ethyl}phenyl)methanesulfonamide“A28”N-(2-{2-[2-(3-Cyanophenylamino)pyrimidin-4-yl]ethyl}-phenyl)-N-methylmethanesulfonamide“A29”N-(2-{2-[2-(3-Cyano-4-fluorophenylamino)pyrimidin-4-yl]-ethyl}phenyl)-N-methylmethanesulfonamide“A30”N-Methyl-N-(2-{2-[2-(2-oxo-2,3-dihydrobenzothiazol-5-ylamino)pyrimidin-4-yl]ethyl}phenyl)methanesulfonamide“A31”N-(2-{2-[2-(1-Acetyl-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)-N-methylmethanesulfonamide“A32”2-[3-(4-{2-[2-(Methanesulfonylmethylamino)phenyl]ethyl}-pyrimidin-2-ylamino)phenyl]-N-methylacetamide“A33”N-Methyl-N-[2-(2-{2-[4-(3-oxomorpholin-4-yl)phenylamino]-pyrimidin-4-yl}ethyl)phenyl]methanesulfonamide“A34”N-[4-(4-{2-[2-(Methanesulfonylmethylamino)phenyl]ethyl}-pyrimidin-2-ylamino)phenyl]nicotinamide“A35”N-Methyl-N-[2-(2-{2-[4-(2-oxopyrrolidin-1-yl)phenylamino]-pyrimidin-4-yl}ethyl)phenyl]methanesulfonamide“A36”N-[2-(2-{2-[3,5-Dichloro-4-(2-oxopyrrolidin-1-yl)phenyl-amino]pyrimidin-4-yl}ethyl)phenyl]-N-methylmethane-sulfonamide“A37”N-[2-(2-{2-[3-Cyano-4-(2-oxopiperidin-1-yl)phenylamino]-pyrimidin-4-yl}ethyl)phenyl]-N-methylmethanesulfonamide“A38”N-[2-(2-{2-[4-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)phenyl-amino]pyrimidin-4-yl}ethyl)phenyl]-N-methylmethane-sulfonamide“A39”N-Methyl-N-[3-(2-{2-[4-(2-oxopyrrolidin-1-yl)phenylamino]-pyrimidin-4-yl}ethyl)pyridin-2-yl]methanesulfonamide“A40”N-[4-(4-{2-[2-(Methanesulfonylmethylamino)pyridin-3-yl]-ethyl}pyrimidin-2-ylamino)phenyl]nicotinamide“A41”N-Methyl-N-[3-(2-{2-[4-(3-oxomorpholin-4-yl)phenylamino]-pyrimidin-4-yl}ethyl)pyridin-2-yl]methanesulfonamide“A42”N-[3-(2-{2-[3-Cyano-4-(2-oxopiperidin-1-yl)phenylamino]-pyrimidin-4-yl}ethyl)pyridin-2-yl]-N-methylmethane-sulfonamide“A43”N-[3-(2-{2-[4-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-phenylamino]pyrimidin-4-yl}ethyl)pyridin-2-yl]-N-methyl-methanesulfonamide“A44”N-Methyl-N-(5-methyl-3-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}pyridin-2-yl)methanesulfonamide“A45”1-(4-Fluoro-2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)cyclobutanecarbonitrile“A46” 1-(5-Fluoro-2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-yl]ethyl}phenyl)cyclobutanecarbonitrile“A47”1-(2-{2-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)pyrimidin-4-yl]ethyl}-5-trifluoromethylphenyl)cyclobutanecarbonitrile“A48”(5-Fluoro-4-phenethylpyrimidin-2-yl)phenylamine“A49”(5-Methyl-4-phenethylpyrimidin-2-yl)phenylamine“A50”(4-Phenethyl-5-trifluoromethylpyrimidin-2-yl)phenylamine“A52”(5-Bromo-4-phenethylpyrimidin-2-yl)phenylamine“A56”6-{5-Fluoro-4-[2-(4-fluorophenyl)ethyl]pyrimidin-2-ylamino}-3,4-dihydro-1H-quinolin-2-one“A65”6-{4-[2-(4-Fluorophenyl)ethyl]-5-methylpyrimidin-2-ylamino}-3,4-dihydro-1H-quinolin-2-one“A71”[5-(1-Methyl-1H-pyrazol-4-yl)-4-phenethylpyrimidin-2-yl]-phenylamine“A74”5-{4-[2-(4-Fluorophenyl)ethyl]-5-trifluoromethylpyrimidin-2-ylamino}-1,3-dihydroindol-2-one“A77”6-{4-[2-(4-Fluorophenyl)ethyl]-5-trifluoromethylpyrimidin-2-ylamino}-3,4-dihydro-1H-quinolin-2-one“A101”6-(5-Bromo-4-phenethylpyrimidin-2-ylamino)-3,4-dihydro-1H-quinolin-2-one“A102”5-(4-Phenethyl-5-trifluoromethylpyrimidin-2-ylamino)-1,3-dihydroindol-2-one“A103”6-(4-Phenethyl-5-trifluoromethylpyrimidin-2-ylamino)-3,4-dihydro-1H-quinolin-2-one“A104”6-(5-Methyl-4-{2-[3-(propane-1-sulfonyl)phenyl]ethyl}-pyrimidin-2-ylamino)-3,4-dihydro-1H-quinolin-2-one“A105”6-(5-Fluoro-4-{2-[3-(propane-1-sulfonyl)phenyl]ethyl}-pyrimidin-2-ylamino)-3,4-dihydro-1H-quinolin-2-one“A106”[6-(4-tert-Butylphenoxy)pyridin-3-yl]-(5-fluoro-4-phenethylpyrimidin-2-yl)amine“A107”(5-Fluoro-4-phenethylpyrimidin-2-yl)-(6-trifluoromethylpyridin-3-yl)amine“A108”(5-Fluoro-4-phenethylpyrimidin-2-yl)-(6-fluoropyridin-3-yl)-amine“A109”5-(5-Fluoro-4-phenethylpyrimidin-2-ylamino)pyridine-2-carbonitrile“A110”N-[5-(5-Fluoro-4-phenethylpyrimidin-2-ylamino)pyridin-2-yl]-acetamide“A111”N-Methyl-N-(2-{2-[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethylpyrimidin-4-yl]ethyl}phenyl)-methanesulfonamideor a pharmaceutically usable salt, tautomer or stereoisomer thereof, including mixtures thereof in all ratios.
地址 Darmstadt DE